Search Results - "Dowidar, Naeem"
-
1
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Published in BMC medical genomics (22-08-2015)“…The four intrinsic subtypes of breast cancer, defined by differential expression of 50 genes (PAM50), have been shown to be predictive of risk of recurrence…”
Get full text
Journal Article -
2
Identification of New Flagellar Genes of Salmonella enterica Serovar Typhimurium
Published in Journal of Bacteriology (01-03-2006)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
3
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Published in BMC cancer (13-03-2014)“…NanoString's Prosigna™ Breast Cancer Prognostic Gene Signature Assay is based on the PAM50 gene expression signature. The test outputs a risk of recurrence…”
Get full text
Journal Article -
4
Direct multiplexed measurement of gene expression with color-coded probe pairs
Published in Nature biotechnology (01-03-2008)“…We describe a technology, the NanoString nCounter gene expression system, which captures and counts individual mRNA transcripts. Advantages over existing…”
Get full text
Journal Article -
5
Validating critical analytical variables of a multiplexed gene expression assay measuring tumor inflammation designed to predict response to anti-PD1 therapy
Published in Journal of clinical oncology (10-02-2018)“…Abstract only 203 Background: The development and analytical performance of the Tumor Inflammation Signature (TIS) assay has been described previously. The TIS…”
Get full text
Journal Article -
6
Verification of the analytical performance of a molecular diagnostic for response to anti-PD1 therapy on the nCounter Dx Analysis System
Published in Journal of clinical oncology (01-03-2017)“…Abstract only 8 Background: Pembrolizumab is a humanized anti-PD1 antibody that is approved for use in advanced melanoma, recurrent or metastatic head and neck…”
Get full text
Journal Article -
7
Analytical Validation of the nCounter®-based Lymphoma Subtyping Test (LST) for Cell-of-Origin (COO) Identification in Formalin-Fixed Paraffin-Embedded (FFPE) Diffuse Large B-Cell Lymphoma (DLBCL) Specimens
Published in Blood (02-12-2016)“…Introduction: Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin’s lymphoma with two distinct molecular subtypes defined by…”
Get full text
Journal Article -
8
Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples
Published in Blood (03-12-2015)“…Background: Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin's lymphoma with two distinct molecular cell-of-origin (COO) subtypes known as…”
Get full text
Journal Article -
9
Development of the molecular diagnostic (MDx) DLBCL Lymphoma Subtyping Test (LST) on the nCounter Analysis System
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
10
Development and analytical performance of a molecular diagnostic for anti-PD1 response on the nCounter Dx Analysis System
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
11
Prosigna (PAM50) to predict response to neoadjuvant chemotherapy (NAC) in HR+/HER2- early breast cancer (EBC) patients
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
12
Blinded independent validation of the PAM50-based Chemo-Endocrine Sensitivity Predictor (CESP) in hormone receptor (HR)-positive/HER2-negative (HR+/HER2-) breast cancer following neoadjuvant chemotherapy (NAC)
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
13
Abstract LB-327: Analytical performance of the nCounter analysis system for gene expression cancer signatures
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Background: The nCounter Analysis System is a platform for performing highly multiplexed, digital quantification of hundreds of different nucleic acid species…”
Get full text
Journal Article -
14
Erratum: Corrigendum: Direct multiplexed measurement of gene expression with color-coded probe pairs
Published in Nature biotechnology (01-06-2008)Get full text
Journal Article -
15
Corrigendum: Direct multiplexed measurement of gene expression with color-coded probe pairs
Published in Nature biotechnology (01-06-2008)Get full text
Journal Article -
16
Correction: Corrigendum: Direct multiplexed measurement of gene expression with color-coded probe pairs
Published in Nature biotechnology (2008)“…Nat. Biotechnol. 26, 317–325 (2008); published online 17 February 2008, corrected after print 16 May 2008 In the version of this article initially published,…”
Get full text
Journal Article